(Q40913178)

24 September 2017

1 reference

title

Construct validity of negative symptoms: an empirical and conceptual review (English)

1 reference

24 September 2017

Earnst KS

1

1 reference

PubMed ID

9140714

24 September 2017

Kring AM

series ordinal

2

1 reference

24 September 2017

1 January 1997

1 reference

Clinical Psychology Review

24 September 2017

1 reference

24 September 2017

17

1 reference

24 September 2017

2

1 reference

24 September 2017

167-189

1 reference

A rating scale for emotional blunting

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative symptoms in schizophrenia. Definition and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Symptoms of schizophrenia. Methods, meanings, and mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: an overview and update

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Diagnosis and classification of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Schizophrenia: the characteristic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative v positive schizophrenia. Definition and validation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The distinction of positive and negative symptoms. The failure of a two-dimensional model

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Nuclear magnetic resonance brain imaging in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Symptomatic and neuropsychological components of defect states.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Flat affect in schizophrenia: a test of neuropsychological models

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Neuroleptic responsivity of negative and positive symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A latent structure analysis of the positive and negative symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Clinical correlates of the deficit syndrome of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Neuroleptic treatment and negative symptoms in deficit and nondeficit schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Psychopathology and common sense.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Strong inference, theory testing, and the neuroanatomy of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Patient response and resource management: another view of clozapine treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Treatment of negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Deficit and nondeficit forms of schizophrenia: the concept

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Measurement of mood and affect in schizophrenic inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Molecular pathology of schizophrenia: more than one disease process?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The two-syndrome concept: origins and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Psychopathological dimensions in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Does affective blunting in schizophrenia reflect affective deficit or neuromotor dysfunction?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Facial expression in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Diagnosis of schizophrenia. Prediction of short-term outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Testing systems for assessment of negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Emotional imagery and physical anhedonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Diagnostic criteria for schizophrenia and related disorders: options for DSM-IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Primary enduring negative symptoms in schizophrenia and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The deficit syndrome in schizophrenic and nonschizophrenic patients: preliminary studies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Stability of Positive and Negative Symptom Constructs during Neuroleptic Treatment in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Clinical genetics as clues to the "real" genetics of schizophrenia (a decade of modest gains while playing for time).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Relations among clinical scales in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Depressive syndromes in the year following onset of a first schizophrenic illness*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative symptoms and the early course of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A Negative Symptom Rating Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The relative stability of positive and negative features in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Institutionalization and the defects of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Positive and negative syndromes in schizophrenia as a function of chronicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Significance of positive and negative syndromes in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The positive-negative distinction in drug-free schizophrenic patients. Stability, response to neuroleptics, and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Cognitive impairment in schizophrenia: Specific relations to ventricular size and negative symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Clinical, biological, and neuropsychological features associated with lateral ventricular enlargement in DSM-III schizophrenic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Case identification and stability of the deficit syndrome of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Depressive symptoms and the deficit syndrome of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Clinical correlates of cerebral ventricular enlargement in schizophrenia. Further evidence for frontal lobe disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A standardized psychiatric assessment scale for rating chronic psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A multimethod, multichannel assessment of affective flattening in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative and depressive symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Frontal lobe dysfunctions in schizophrenia--II. Impairments of psychological and brain functions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Premorbid adjustment in schizophrenia: implications for psychosocial and ventricular pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Assessment of negative and positive symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Schizophrenic syndromes, cognitive performance and neurological dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Syndromes of chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Signs and symptoms. What can they tell us about the clinical course and pathophysiologic processes of schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative and positive schizophrenic syndromes after the acute phase: a prospective follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Correlates of lateral ventricular size in chronic schizophrenia, I: Behavioral and treatment response measures

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Positive and negative schizophrenic symptoms and the role of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Stability of positive and negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Three syndrome concept of schizophrenia. A factor analytic study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Validity of the negative/positive dichotomy of schizophrenic disorders under long-term conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Multiple contributions to clinical presentation of flat affect in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The deficit state in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Assessment of Enduring Deficit and Negative Symptom Subtypes in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The disabilities of chronic schizophrenia--their nature and the factors contributing to their development.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Ventricle-brain ratio, computed tomographic density, and brain area in 50 schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Positive and negative symptoms/syndromes in schizophrenia: reliability and validity of different diagnostic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative symptoms are related to both frontal and nonfrontal neuropsychological measures in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Computed Tomographic Evidence for Generalized Sulcal and Ventricular Enlargement in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative and positive symptoms in schizophrenia and depression: a followup

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative symptoms in schizophrenia: their longitudinal course and prognostic importance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Five-year outcome and prognosis in schizophrenia: a report from the London Field Research Centre of the International Pilot Study of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Poverty of speech in schizophrenia and depression during in-patient and post-hospital periods

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The motor disorders of severe psychiatric illness: a conflict of paradigms.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Structural and functional correlates of subsyndromes in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

"Negative symptoms": conceptual and methodological problems

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Neuropsychological correlates of alogia and affective flattening in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative symptoms of schizophrenia: the need for conceptual clarity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Positive, negative, and disorganisation factors from the Schedule for Affective Disorders and Schizophrenia and the Present State Examination. A three-factor solution.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Risperidone: efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The positive/negative symptom distinction in schizophrenia. Validity and etiological relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Schizophrenia with good and poor outcome. II: Cerebral ventricular size and its clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Negative symptoms and hypofrontality in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Emotional experience and expression in schizophrenia and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Neuropsychological performance and positive and negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Concurrent and predictive validity of thought disorder and affectivity: a 22-year follow-up of acute schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Flat affect in schizophrenia does not reflect diminished subjective experience of emotion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Do schizophrenic patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Models of positive and negative symptoms in schizophrenia: an empirical evaluation of latent structures

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

The advantages of studying psychological phenomena rather than psychiatric diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

Toward the integration of classification theory and methods

1 reference

https://api.crossref.org/works/10.1016%2FS0272-7358%2896%2900052-9

7 January 2021

10.1016/S0272-7358(96)00052-9

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9140714